The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies.

ABSTRACT:

Background

While progress has been made in oncology treatments, including the introduction of combination therapies, barriers affect patient access. There are approaches that could improve access including combination-specific pricing that allow the price to reflect whether a product is used in monotherapy or in combination. The feasibility of this solution requires data on the utilization of combination therapies.

Aim

To investigate the ability of data systems across Belgium, England, France, Italy, Spain, Sweden, Switzerland and Australia to track drug utilization of combination therapies, particularly in oncology.

Methods

A targeted literature review was conducted to investigate the attributes of the key data systems. One-on-one semi-structured interviews were subs

SUBMITTER: Simoens S 

PROVIDER: S-EPMC12406276 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature